Compact Ultrasound Scanner Measures Bladder Volume 
|
By HospiMedica International staff writers Posted on 21 Jan 2015 |
|
Image: The BBS Revolution automated bladder volume measurement device (Photo courtesy of dBMEDx).
An automatic bladder volume measurement device provides rapid, objective information on the necessity for a urinary catheter.
The BBS Revolution automated bladder volume measurement device is an ultrasound based system that requires only a short sweep across the abdomen to automatically calculate bladder volume and display the reading on a screen. The whole process takes just minutes to complete, and can be performed by staff that have not necessarily been trained in using ultrasound equipment. The underlying technology uses a proprietary algorithm to produce a true three dimensional (3D) volume dataset, using multiple b-mode slices.
The BBS Revolution is battery powered and pole mounted, with a palm-sized, compact probe that is inductively charged when docked in the console. The probe performs image collection and analysis automatically, transferring the results wirelessly via integrated Bluetooth wireless radio to a wide range of potential display platforms and mobile devices. The BBS Revolution automated bladder volume measurement device is a product of dBMEDx (Denver, CO, USA), and has been approved by the US Food and Drug Administration (FDA).
“The initial use will be to check the volume of urine in a patient’s bladder. When you’re in the hospital, you typically have to go to the bathroom before you can leave. If that doesn’t happen, it may be that you need to drink more water or there might be a true medical problem,” said David Shine, CEO of dBMEDx. “The real value with this is that you don’t have to put a catheter in someone to find out. Medicare is not paying for these infections if a patient acquires the infection during a hospital stay, so hospitals are very motivated not to have these infections occur.”
Bladder volume measurement is a well-established metric used in the diagnosis and treatment of a wide range of medical conditions, including urinary tract infections (UTI). It is a critical component of a comprehensive catheter-associated urinary tract infection (CAUTI) prevention program, an area of intense focus for hospitals given recent Medicare penalties for hospitals with high CAUTI rates, which include reducing payments by one percent for hospitals with a high number of hospital acquired conditions (HACs).
Related Links:
dBMEDx
The BBS Revolution automated bladder volume measurement device is an ultrasound based system that requires only a short sweep across the abdomen to automatically calculate bladder volume and display the reading on a screen. The whole process takes just minutes to complete, and can be performed by staff that have not necessarily been trained in using ultrasound equipment. The underlying technology uses a proprietary algorithm to produce a true three dimensional (3D) volume dataset, using multiple b-mode slices.
The BBS Revolution is battery powered and pole mounted, with a palm-sized, compact probe that is inductively charged when docked in the console. The probe performs image collection and analysis automatically, transferring the results wirelessly via integrated Bluetooth wireless radio to a wide range of potential display platforms and mobile devices. The BBS Revolution automated bladder volume measurement device is a product of dBMEDx (Denver, CO, USA), and has been approved by the US Food and Drug Administration (FDA).
“The initial use will be to check the volume of urine in a patient’s bladder. When you’re in the hospital, you typically have to go to the bathroom before you can leave. If that doesn’t happen, it may be that you need to drink more water or there might be a true medical problem,” said David Shine, CEO of dBMEDx. “The real value with this is that you don’t have to put a catheter in someone to find out. Medicare is not paying for these infections if a patient acquires the infection during a hospital stay, so hospitals are very motivated not to have these infections occur.”
Bladder volume measurement is a well-established metric used in the diagnosis and treatment of a wide range of medical conditions, including urinary tract infections (UTI). It is a critical component of a comprehensive catheter-associated urinary tract infection (CAUTI) prevention program, an area of intense focus for hospitals given recent Medicare penalties for hospitals with high CAUTI rates, which include reducing payments by one percent for hospitals with a high number of hospital acquired conditions (HACs).
Related Links:
dBMEDx
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Radiofrequency Generator
GX1
New
Syringe Pump
SP50 Series
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
